Press Release: Jeffrey Modell Foundation : Jeffrey Modell Foundation and X4 Pharmaceuticals to Sponsor First Genetic Screening Study for Patients with WHIM Syndrome

NEW YORK & CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Jeffrey Modell Foundation and X4 Pharmaceuticals are jointly sponsoring the first genetic screening study for patients with WHIM Syndrome.